Table 1 Characteristics of study participants*

From: Deficiency of flavin-containing monooxygenase 3 protects kidney function after ischemia–reperfusion in mice

Variable

Non-AKI group, (n = 18)

AKI group, (n = 9)

P value

Demographics

 Age (y, mean ± SD)

57.39 ± 10.91

60.33 ± 6.29

0.463

 Female (n, %)

8 (44.44)

4 (44.44)

>0.999

 BMI (kg/m2, mean ± SD)

23.10 ± 2.94

23.93 ± 3.71

0.528

 Smoking (n, %)

4 (22.22)

1 (11.111)

0.636

 Drinking (n, %)

4 (22.22)

1 (11.111)

0.636

Medical history

 Hypertension (n, %)

9 (50.00)

5 (55.56)

>0.999

 Diabetes (n, %)

2(11.11)

1 (11.11)

>0.999

 Pulmonary diseases (n, %)

1 (0.06)

0 (0)

>0.999

 Cerebral vascular diseases (n, %)

0 (0)

1 (11.11)

0.333

Surgical variables

 Cardiac surgical procedure

  Valve surgery (n, %)

5 (27.78)

3 (33.33)

>0.999

  CABG + valve (n, %)

7 (38.89)

4 (44.44)

>0.999

  Other cardiac surgery (n, %)

6 (33.33)

2 (22.22)

0.676

 Duration of surgery (min, median [IQR])

298.00 (218.50–370.00)

327.50 (277.00–423.50)

0.201

 CPB time (min, median [IQR])

143.00 (92.50–192.50)

190 (137.00–195.00)

0.138

 Duration of hypotension (min, median [IQR])

30.00 (17.50–42.05)

60.00 (22.50–77.50)

0.160

Preoperative laboratory values

 ALB (g/L, median [IQR])

42.00 (39.20–43.40)

43.65 (38.68–44.98)

0.705

 ALT (g/L, median [IQR])

15.00 (7.50–19.00)

15.50 (10.50–20.75)

0.596

 AST (g/L, median [IQR])

18.00 (15.00–20.50)

18.50 (14.25–22.25)

0.958

 HGB (g/L, median [IQR])

130.00 (116.50–143.50)

137.00 (126.75–152.50)

0.176

Total ICU stay (h, median [IQR])

18.00 (14.50–21.00)

18.00 (13.50–26.50)

0.743

Total stay in hospital (d, median [IQR])

24.00 (20.00–35.00)

17.00 (14.00–19.50)

0.429

  1. Categorical and continuous variables are reported as N (%) and median (IQR), respectively.
  2. ICU length of stay is the number of hours from admission to ICU until discharge to the ward.
  3. Total stay in the hospital is the number of days from admission to the hospital preoperatively to discharge home postoperatively.
  4. BMI body mass index, CABG coronary artery bypass grafting, CPB cardiopulmonary bypass, ALB albumin, ALT alanine aminotransferase, AST aspartate aminotransferase, HGB hemoglobin, ICU intensive care unit, IQR interquartile range.
  5. *Clinical, demographic, and laboratory characteristics for 9 AKI and 18 non-AKI patients were summarized in the table.